These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9693155)

  • 1. Immunopathogenesis of Mycobacterium avium infection.
    Cooper AM; Appelberg R; Orme IM
    Front Biosci; 1998 Aug; 3():e141-8. PubMed ID: 9693155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.
    Appelberg R; Sarmento A; Castro AG
    Clin Exp Immunol; 1995 Aug; 101(2):308-13. PubMed ID: 7648714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host defense against Mycobacterium-avium complex.
    Schnittman S; Lane HC; Witebsky FG; Gosey LL; Hoggan MD; Fauci AS
    J Clin Immunol; 1988 Jul; 8(4):234-43. PubMed ID: 2842366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104.
    Saunders BM; Dane A; Briscoe H; Britton WJ
    Immunol Cell Biol; 2002 Dec; 80(6):544-9. PubMed ID: 12406388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
    Appelberg R; Sarmento AM
    Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis.
    Sow FB; Florence WC; Satoskar AR; Schlesinger LS; Zwilling BS; Lafuse WP
    J Leukoc Biol; 2007 Oct; 82(4):934-45. PubMed ID: 17609338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the virulence for mice of Mycobacterium avium and Mycobacterium intracellulare identified by DNA probe test.
    Tomioka H; Saito H; Sato K; Dawson DJ
    Microbiol Immunol; 1993; 37(4):259-64. PubMed ID: 8350768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IL-18 by Mycobacterium avium-infected human monocytes; association with M. avium virulence.
    Shiratsuchi H; Ellner JJ
    Clin Exp Immunol; 2001 Feb; 123(2):203-9. PubMed ID: 11207649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
    Bruffaerts N; Vluggen C; Roupie V; Duytschaever L; Van den Poel C; Denoël J; Wattiez R; Letesson JJ; Fretin D; Rigouts L; Chapeira O; Mathys V; Saegerman C; Huygen K
    PLoS One; 2017; 12(2):e0171895. PubMed ID: 28182785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-α and interleukin-10.
    Klug K; Ehlers S; Uhlig S; Reiling N
    Innate Immun; 2011 Oct; 17(5):470-85. PubMed ID: 20682586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice.
    Pedrosa J; Flórido M; Kunze ZM; Castro AG; Portaels F; McFadden J; Silva MT; Appelberg R
    Clin Exp Immunol; 1994 Nov; 98(2):210-6. PubMed ID: 7955524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response.
    Cross ML; Labes RE; Mackintosh CG
    J Comp Pathol; 2000 Jul; 123(1):15-21. PubMed ID: 10906251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.
    Cha SB; Jeon BY; Kim WS; Kim JS; Kim HM; Kwon KW; Cho SN; Shin SJ; Koh WJ
    PLoS One; 2015; 10(9):e0139251. PubMed ID: 26406237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
    Castro AP; Aguas AP; Silva MT
    Clin Exp Immunol; 1993 Jun; 92(3):466-72. PubMed ID: 8513578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species.
    Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ
    Scand J Immunol; 2001; 54(1-2):163-70. PubMed ID: 11439163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of Mycobacterium avium in mice does not correlate with resistance to nitric oxide.
    Lousada S; Flórido M; Appelberg R
    Microb Pathog; 2007; 43(5-6):243-8. PubMed ID: 17683898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.